Limited Stage Aggressive Non-Hodgkin Lymphoma: What Is Optimal Therapy?
Crossref DOI link: https://doi.org/10.1007/s11864-016-0424-2
Published Online: 2016-07-16
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kumar, Abhijeet
Sundararajan, Srinath
Puvvada, Soham
Persky, Daniel O.
License valid from 2016-07-16